These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36692540)

  • 1. [How to: clinical use of antiarrhythmic drugs].
    Hillmann HAK; Betz K; Linz D; Duncker D
    Herzschrittmacherther Elektrophysiol; 2023 Mar; 34(1):82-90. PubMed ID: 36692540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiarrhythmic drugs in the present day].
    Allgaier R; Duncker D
    Inn Med (Heidelb); 2024 Aug; 65(8):762-769. PubMed ID: 39009875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy of cardiac arrhythmias 199].
    Dietz A; Manz M
    Fortschr Med; 1997 Nov; 115(33):32, 34-6, 38. PubMed ID: 9480278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications].
    Pott C; Dechering DG; Muszynski A; Zellerhoff S; Bittner A; Wasmer K; Mönnig G; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):228-38. PubMed ID: 21113605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic mechanisms of the new antiarrhythmic drugs in atrial fibrillation].
    Filgueiras-Rama D; Castrejón S; Calvo C; Estrada A; Doiny D; Ortega M; Berenfeld O; Merino JL; Jalife J
    Arch Cardiol Mex; 2012; 82(2):139-52. PubMed ID: 22735655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG; Camm AJ
    Drugs; 1995 Aug; 50(2):250-62. PubMed ID: 8521758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atria-selective antiarrhythmic drugs in need of alliance partners.
    Peyronnet R; Ravens U
    Pharmacol Res; 2019 Jul; 145():104262. PubMed ID: 31059791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of arrhythmias in the elderly.
    Van Gelder IC; Brügemann J; Crijns HJ
    Drugs Aging; 1997 Aug; 11(2):96-110. PubMed ID: 9259173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacological approaches for antiarrhythmic therapy.
    Ravens U
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):187-93. PubMed ID: 20082192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is There Still a Need for Medical Antiarrhythmic Therapy?].
    Fischer TH
    Dtsch Med Wochenschr; 2020 Apr; 145(8):526-535. PubMed ID: 32294778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in arrhythmia therapy: treatment and prevention of atrial fibrillation.
    Bril A
    Curr Opin Pharmacol; 2002 Apr; 2(2):154-9. PubMed ID: 11950626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late sodium current inhibition: the most promising antiarrhythmic principle in the near future?
    Frommeyer G; Milberg P; Maier LS; Eckardt L
    Curr Med Chem; 2014; 21(11):1271-80. PubMed ID: 23992336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Flaker GC; Blackshear JL; McBride R; Kronmal RA; Halperin JL; Hart RG
    J Am Coll Cardiol; 1992 Sep; 20(3):527-32. PubMed ID: 1512329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.